BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19172091)

  • 21. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer.
    Davison BJ; So AI; Goldenberg SL
    BJU Int; 2007 Oct; 100(4):780-5. PubMed ID: 17578466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
    Moinpour CM; Hayden KA; Unger JM; Thompson IM; Redman MW; Canby-Hagino ED; Higgins BA; Sullivan JW; Lemmon D; Breslin S; Crawford ED; Southwest Oncology Group
    J Clin Oncol; 2008 Jan; 26(1):112-20. PubMed ID: 18165645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE.
    Mehta SS; Lubeck D; Pasta DJ; Litwin MS
    J Urol; 2003 Nov; 170(5):1931-3. PubMed ID: 14532810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sexual function after radical prostatectomy does not affect global patient satisfaction].
    Descazeaud A; Chaskalovic J; Debré B; Zerbib M; Peyromaure M
    Prog Urol; 2004 Dec; 14(6):1177-80. PubMed ID: 15751413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of quality of life of patients receiving treatment for prostate cancer.
    Eller LS; Lev EL; Gejerman G; Colella J; Esposito M; Lanteri V; Scheuch J; Munver R; Lane P; Junchaya C; Alves L; Galli B; Watson R; Sawczuk I
    Nurs Res; 2006; 55(2 Suppl):S28-36. PubMed ID: 16601630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
    Choo R; Pearce A; Danjoux C; Morton G; Deboer G; Szumacher E; Loblaw A; Cheung P
    Eur Urol; 2007 Dec; 52(6):1645-50. PubMed ID: 17140722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy.
    Köhler TS; Pedro R; Hendlin K; Utz W; Ugarte R; Reddy P; Makhlouf A; Ryndin I; Canales BK; Weiland D; Nakib N; Ramani A; Anderson JK; Monga M
    BJU Int; 2007 Oct; 100(4):858-62. PubMed ID: 17822466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
    Feigenberg SJ; Lee WR; Desilvio ML; Winter K; Pisansky TM; Bruner DW; Lawton C; Morton G; Baikadi M; Sandler H
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):956-64. PubMed ID: 15989995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function.
    Schiff JD; Bar-Chama N; Cesaretti J; Stock R
    BJU Int; 2006 Dec; 98(6):1255-8. PubMed ID: 17125483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer.
    Fransson P
    Acta Oncol; 2005; 44(4):355-61. PubMed ID: 16120544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
    Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
    Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
    BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.
    Bacon CG; Giovannucci E; Testa M; Kawachi I
    J Urol; 2001 Nov; 166(5):1804-10. PubMed ID: 11586228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brachytherapy-related dysuria.
    Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Lief JH
    BJU Int; 2005 Mar; 95(4):597-602. PubMed ID: 15705087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
    Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.